Estrigenix Therapeutics: Funding, Investors & Team (Sep 2026)
Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.
Estrigenix Therapeutics has raised $2.0M across 2 funding rounds on record, the most recent a Seed of $2.0M announced in Jul 2026.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Estrigenix Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Estrigenix Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Estrigenix Therapeutics announced a Seed in Mar 2023; the amount was not disclosed.
3.3 years later, a Seed of $2.0M was announced in Jul 2026.
Estrigenix Therapeutics Investors
Estrigenix Therapeutics Founders and Leadership Team
Contact details for the Estrigenix Therapeutics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Estrigenix Therapeutics Funding Compared to Other Health Care Startups
Estrigenix Therapeutics' latest round of $2.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Estrigenix Therapeutics in Health Care and Milwaukee
Companies Similar to Estrigenix Therapeutics
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Estrigenix Therapeutics Funding FAQs
What does Estrigenix Therapeutics do?
Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.
How much funding has Estrigenix Therapeutics raised?
Estrigenix Therapeutics has raised $2.0M across 2 rounds on record. The most recent is a Seed of $2.0M announced in Jul 2026.
When did Estrigenix Therapeutics last raise funding?
Estrigenix Therapeutics' most recent funding round on record is a Seed of $2.0M, announced in Jul 2026.
Who has invested in Estrigenix Therapeutics?
Investors on record for Estrigenix Therapeutics include Talents Fund, Small Business Innovation Research, San Diego Angel Conference.
Who is the CEO of Estrigenix Therapeutics?
Victoria Zellmer is listed as Chief Executive Officer at Estrigenix Therapeutics.
Where is Estrigenix Therapeutics headquartered?
Estrigenix Therapeutics is based in Milwaukee, Wisconsin, United States.
How many employees does Estrigenix Therapeutics have?
Estrigenix Therapeutics is in the 1-10 employee band.
When was Estrigenix Therapeutics founded?
Estrigenix Therapeutics was founded in 2018.
How does Estrigenix Therapeutics' funding compare to other Health Care startups?
Estrigenix Therapeutics' latest round of $2.0M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Estrigenix Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Estrigenix Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.